PoS 2
ePoster 04

Programm

• • ePoster
  • P230

  Observational prospective study on the presence of typical migraine features in nummular headache patients: The Numamig study (NCT04299958)

  • David García Azorín (Valladolid, ES)
• • ePoster
  • P231

  Familial hemiplegic migraine caused by simultaneous mutations in ATP1A2 and SCN1A, a new subtype?

  • Tao Wang (Beijing, CN)
• • ePoster
  • P232

  Photophobia in headache disorders: characteristics and potential mechanisms

  • Zheman Xiao (Wuhan, CN)
• • ePoster
  • P233

  Proteomics profiling reveals mitochondrial damage in the thalamus in a mouse model of chronic migraine

  • Wei Xie (Beijing, CN)
• • ePoster
  • P234

  The thalamic ventral posterior nuclear complex involvement in the migraine cycle: a task-free fMRI analysis during nitroglycerin-induced migraine like attacks

  • Maria Magdalena Pocora (Pavia, IT)
• • ePoster
  • P236

  The gut microbial features in migraine patients

  • Wenjing Tang (Beijing, CN)
• • ePoster
  • P237

  Introduction of a standardised interview to identify post-traumatic headache

  • Hannah Lyons (Birmingham, GB)
• • ePoster
  • P238

  A multi-centre, real-world study of migraine-like headache in mitochondrial diseases

  • Changping Yan (Beijing, CN)
• • ePoster
  • P239

  Pain thresholds in patients with migraine assessed by quantitative sensory testing

  • Katarina Alexandra Ebner (Basel, CH)
• • ePoster
  • P129

  Worst Headache Neurocriptococcosis in an immunocompetent patient: a case report

  • Eliana Melhado (Catanduva, BR)
• • ePoster
  • LP035

  No wearing-off effect of erenumab or fremanezumab for chronic migraine prevention: a single-center, real world, observational study

  • Samaira Younis (2600, DK)